Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00495404 · ClinicalTrials.gov registry record · NA

Health Outcomes From Opioid Therapy for Chronic Pain

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
135
Enrollment target

NCT00495404 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 135 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00495404, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
135 participants
Enrollment target

Study Summary

Although the use of opioid medications has gained increasing acceptance as a treatment option for chronic pain, there is little empirical research concerning long-term outcomes with this patient population. Several important questions concerning the use of opioids have yet to be examined in controlled studies. These include: determination of the most effective dosing regime, specification of the risk factors for medication abuse, and identification of patients most likely to achieve long-term benefits. Despite the lack of empirical data, the clinical literature to date yields two general approaches to the use of opioid treatment with chronic, nonmalignant pain. The first approach dictates that due to risk of addiction, tolerance, and insensitivity to large doses, opioid medications should be carefully controlled, with minimal and stable dosing as the eventual goal of treatment. The second approach, fostered by the beneficial use of opioids in the treatment of cancer pain, maintains that risk of addiction and abuse has been exaggerated. Proponents of this approach suggest that under-medication is a significant cause of treatment failure and non-compliance in chronic pain patients, and that prescription guidelines should emphasize patients� reports of adequate relief, regardless of dosage.

Interventions

  • BEHAVIORAL Physician Treatment Guidelines

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2001-08
Est. Completion 2005-03
Phase NA

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00495404

The ClinicalTrials.gov registry entry for NCT00495404 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Physician Treatment Guidelines is the first listed.

NCT00495404 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00495404 about?

NCT00495404 is a clinical study titled "Health Outcomes From Opioid Therapy for Chronic Pain". Although the use of opioid medications has gained increasing acceptance as a treatment option for chronic pain, there is little empirical research concerning long-term outcomes with this patient population. Several important questions concerning the use of opioids have yet to be examined in controll...

What is the current status of trial NCT00495404?

This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2001-08. Estimated completion is 2005-03.

What interventions are being tested in trial NCT00495404?

The interventions under investigation include: Physician Treatment Guidelines (BEHAVIORAL).

Who is sponsoring clinical trial NCT00495404?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.